… In MCF-7 cells and in T47D cells has been reported the expression of a membrane
androgen receptor (mAR) and in estrogen receptor negative breast cancer MDA-MB 453 cells, …

… Androgen receptor–targeted treatments for breast cancer are … strategies for AR-positive breast
cancer. Further preclinical and … to improve survival outcome in patients with breast cancer. …

… androgen-mediated growth in ER– breast cancer cells in vitro and in vivo The MDA-MB-453
breast cancer … apocrine or luminal androgen receptor subtype of breast cancer with high …

… To understand the genomic action of androgens and AR in ER–/HER2+ breast cancer, …
breast cancer cells treated with 5α-dihydrotestosterone (DHT). This ER–/HER2+ breast cancer …

… (PR) in human breast tumors, its role in breast cancer is poorly understood. … of androgens
have been described in human breast cancer cell lines. The mechanisms by which androgens …

… the role of androgen signalling pathways in breast cancer is … utilising androgen receptor
(AR) antagonists as breast cancer … the role of androgen signalling in breast tumourigenesis will …

… of breast cancer and across the three main breast cancer … androgen receptor-positive triple
negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor …

… Complete response of metastatic androgen receptor-positive breast cancer to bicalutamide:
… cases of androgen receptor-expressing positive breast cancer. British Journal of Cancer 114 …

… (PR) is associated with better outcome in women with breast cancer ( 1 , 2 … androgens and
the androgen receptor (AR) as prognostic markers and as therapeutic targets in breast cancer …

… ► Triple negative breast cancer (TNBC) is a current clinical problem. ► There is a lack of
targeted therapies for TNBC in contrast to other breast cancers. ► Androgen receptor is found …